| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total assets | 422,058 | 303,519 | ||
| Total stockholders' equity (deficit) | 379,436 | 262,238 | ||
| Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit) | 422,058 | 303,519 | ||
Maze Therapeutics, Inc. (MAZE)
Maze Therapeutics, Inc. (MAZE)